Your email has been successfully added to our mailing list.

×
-0.0527298180121325 -0.0527298180121325 -0.0527298180121325 -0.0527298180121325 -0.0480634624358375 -0.0480634624358375 -0.0480634624358375 -0.0667288847410173
Stock impact report

Zealand Pharma initiates several Phase 3 studies and grows cash position in the first quarter of 2019

Zealand Pharma A/S - American Depositary Shares (ZEAL) 
Last zealand pharma a/s - american depositary shares earnings: 11/15 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: zealandpharma.com
Company Research Source: GlobeNewswire
Company announcement – No. 16 / 2019 Zealand Pharma initiates several Phase 3 studies and grows cash position in the first quarter of 2019   Copenhagen, May 16, 2019 – Zealand Pharma A/S (“Zealand”) (Nasdaq: ZEAL) (CVR No. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of next generation peptide medicines, today announced financial results for the quarter ended March 31, 2019.   Emmanuel Dulac, President and Chief Executive Officer at Zealand Pharma, comments:“Zealand Pharma is off to a strong start in 2019. Already this year, we have initiated three Phase 3 studies: one study in short bowel syndrome and two studies in congenital hyperinsulinism. Earlier this week, we announced results from a confirmatory Phase 3 study for dasiglucagon HypoPal® that reiterated the speed and efficacy of this as potential treatment for severe hypoglycemia. In addition, a collaboration announced in March with Alexion leverages their leadership in Show less Read more
Impact Snapshot
Event Time:
ZEAL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ZEAL alerts
Opt-in for
ZEAL alerts

from News Quantified
Opt-in for
ZEAL alerts

from News Quantified